Candela Corporation
23
0
3
14
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
4.3%
1 terminated/withdrawn out of 23 trials
93.3%
+6.8% vs industry average
4%
1 trials in Phase 3/4
57%
8 of 14 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (23)
Vbeam Pro Pulse Dye Laser for the Treatment of Vascular Conditions
Role: lead
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
Role: lead
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
Role: lead
Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD
Role: lead
Clinical Study to Evaluate the Efficacy and Safety of Matrix Pro Treatment
Role: lead
Functional Usability and Feasibility Testing of the Profound Matrix™ System
Role: lead
Safety and Efficacy of Matrix Pro for Eyebrow Lift and Lift of Submental/Neck Laxity
Role: lead
A Retrospective Review Evaluating the Matrix Pro Applicator for Treatment of Wrinkles
Role: lead
PicoWay™ 730 Resolve Fusion for Benign Pigmented Lesions and Wrinkles
Role: lead
Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro Plus
Role: lead
Determination of Safety and Efficacy of a Laser With Cooling for Treatment of Skin
Role: lead
Nonablative Fractional Diode Laser for Treatment of Pigmented Lesions
Role: lead
Nonablative Fractional Diode Laser for Treatment of Skin Resurfacing and Pigmented Lesions
Role: lead
Clinical Evaluation to Demonstrate the Safety and Performance of the Candela PicoWay System™
Role: lead
Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro™/GentleMax Pro Plus™
Role: lead
Combined Bipolar Radiofrequency&Pulsed Dye Laser Treatment
Role: collaborator
Measurement Skin Temperature During Pulsed Laser Exposure
Role: collaborator
Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening
Role: collaborator
Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea
Role: lead
The CO2RE® System for Vulvar Lichen Sclerosus
Role: lead